(Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 6.13%419.31M | 3.80%396.78M | 5.15%416.46M | 23.67%1.6B | 10.53%423.53M | 25.87%395.1M | 24.92%382.25M | 37.43%396.06M | 38.84%1.29B | 27.54%383.19M |
Cost of revenue | 6.65%182.03M | -4.31%175.75M | -3.43%169.72M | 19.90%712.96M | 5.57%182.86M | 13.76%170.69M | 28.80%183.66M | 36.50%175.75M | 19.02%594.61M | 23.87%173.22M |
Gross profit | 5.74%237.28M | 11.30%221.02M | 11.99%246.73M | 26.89%883.97M | 14.62%240.67M | 36.96%224.41M | 21.53%198.58M | 38.19%220.31M | 61.84%696.66M | 30.74%209.97M |
Operating expense | -19.05%53.61M | 812.75%49.6M | 32.98%64.29M | 31.64%195.19M | 472.64%87.58M | 41.80%66.23M | -115.83%-6.96M | 14.24%48.35M | -12.47%148.28M | -61.23%15.29M |
Staff costs | ---- | ---- | ---- | -11.11%98.81M | ---- | ---- | ---- | ---- | 17.72%111.16M | ---- |
Selling and administrative expenses | -9.82%48.45M | 25.21%54.38M | 8.82%53.62M | 33.77%63.89M | -42.88%-82.54M | 25.81%53.72M | 47.61%43.43M | 47.50%49.28M | 0.78%47.76M | 35.89%-57.77M |
-Selling and marketing expense | ---- | ---- | ---- | -7.76%10.77M | ---- | ---- | ---- | ---- | 49.49%11.67M | ---- |
-General and administrative expense | -9.82%48.45M | 25.21%54.38M | 8.82%53.62M | 47.20%53.12M | -34.37%-93.31M | 25.81%53.72M | 47.61%43.43M | 47.50%49.28M | -8.83%36.09M | 29.09%-69.44M |
Depreciation and amortization | ---- | ---- | ---- | 4.16%11.44M | ---- | ---- | ---- | ---- | -23.40%10.98M | ---- |
-Depreciation | ---- | ---- | ---- | 4.16%11.44M | ---- | ---- | ---- | ---- | -23.40%10.98M | ---- |
Rent and land expenses | ---- | ---- | ---- | 15.50%1.2M | ---- | ---- | ---- | ---- | -15.18%1.04M | ---- |
Other operating expenses | -26.59%9.18M | -14.16%982K | 5.25%21.94M | 2,948.41%40.24M | 132.18%15.88M | -25.71%12.5M | -94.16%1.14M | 46.35%20.84M | -95.46%1.32M | -304.97%-49.35M |
Total other operating income | --4.02M | -88.81%5.77M | -48.26%11.27M | -15.02%20.39M | -5,635.32%-42.79M | ---- | 919.08%51.54M | 308.48%21.77M | 40.66%23.99M | -82.83%773K |
Operating profit | 16.11%183.67M | -16.60%171.42M | 6.09%182.44M | 25.60%688.78M | -21.36%153.09M | 35.03%158.18M | 72.09%205.54M | 46.84%171.96M | 110.06%548.38M | 60.69%194.68M |
Net non-operating interest income (expenses) | 6.53%-31.02M | 5.45%-34.28M | 10.82%-32.7M | -11.38%-138.99M | 6.40%-32.88M | -6.22%-33.19M | -28.66%-36.26M | -21.27%-36.66M | -1.21%-124.79M | -8.99%-35.13M |
Non-operating interest income | -12.95%14.07M | -1.89%13.01M | -7.92%12.03M | 49.74%57.47M | 42.84%14.99M | 29.97%16.17M | 82.74%13.26M | 59.36%13.06M | 12.13%38.38M | -7.00%10.49M |
Non-operating interest expense | -8.63%45.1M | -4.50%47.28M | -10.05%44.72M | 20.40%196.46M | 4.93%47.87M | 12.99%49.36M | 39.73%49.51M | 29.39%49.72M | 3.58%163.17M | 4.85%45.62M |
Net investment income | 251.01%58.89M | -847.11%-39M | ||||||||
Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
Income from associates and other participating interests | -37.57%6.36M | 5.02%13.68M | 40,421.36%124.59M | -66.78%22.47M | -146.67%-434K | -54.27%10.19M | -52.13%13.03M | -101.79%-309K | 1,267.95%67.65M | 215.25%930K |
Special income (charges) | 45.91%-16.82M | -115.28%-31.1M | ||||||||
Less:Impairment of capital assets | ---- | ---- | ---- | -86.62%4.6M | ---- | ---- | ---- | ---- | --34.39M | ---- |
Less:Other special charges | ---- | ---- | ---- | -67.82%-3.87M | ---- | ---- | ---- | ---- | 98.87%-2.31M | ---- |
Less:Write off | ---- | ---- | ---- | 1,735.37%16.09M | ---- | ---- | ---- | ---- | -893.55%-984K | ---- |
Other non-operating income (expenses) | ||||||||||
Income before tax | 17.63%159.01M | -17.27%150.83M | 103.22%274.34M | 45.87%614.33M | 79.06%161.84M | 24.96%135.18M | 53.89%182.31M | 29.67%134.99M | 19.84%421.14M | -69.66%90.38M |
Income tax | 21.11%36M | -2.75%27.37M | 12.80%32.89M | 21.75%113.41M | -8.15%26.39M | 50.98%29.72M | 9.38%28.14M | 53.39%29.16M | -16.89%93.15M | 10.52%28.73M |
Net income | 16.65%123.01M | -19.92%123.46M | 128.13%241.45M | 52.72%500.92M | 119.71%135.45M | 19.17%105.46M | 66.23%154.17M | 24.38%105.84M | 37.05%327.99M | -77.33%61.65M |
Net income continuous operations | 16.65%123.01M | -19.92%123.46M | 128.13%241.45M | 52.72%500.92M | 119.71%135.45M | 19.17%105.46M | 66.23%154.17M | 24.38%105.84M | 37.05%327.99M | -77.33%61.65M |
Noncontrolling interests | 3.99%49.32M | 14.61%48.28M | 12.74%56.11M | 11.92%189.01M | 15.86%49.68M | 16.64%47.43M | -1.93%42.13M | 17.46%49.77M | 117.96%168.87M | 12.39%42.88M |
Net income attributable to the company | 26.99%73.69M | -32.90%75.18M | 230.56%185.34M | 96.03%311.91M | 357.02%85.77M | 21.32%58.03M | 125.03%112.04M | 31.24%56.07M | -1.69%159.11M | -91.97%18.77M |
Preferred stock dividends | ||||||||||
Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net income attributable to common stockholders | 26.99%73.69M | -32.90%75.18M | 230.56%185.34M | 96.03%311.91M | 357.02%85.77M | 21.32%58.03M | 125.03%112.04M | 31.24%56.07M | -1.69%159.11M | -91.97%18.77M |
Gross dividend payment | ||||||||||
Basic earnings per share | 28.84%0.0554 | -32.65%0.0559 | 231.57%0.1376 | 96.35%0.2311 | 357.55%0.0636 | 21.47%0.043 | 125.54%0.083 | 31.61%0.0415 | -2.83%0.1177 | -92.03%0.0139 |
Diluted earnings per share | 28.84%0.0554 | -32.65%0.0559 | 231.57%0.1376 | 96.35%0.2311 | 357.55%0.0636 | 21.47%0.043 | 125.54%0.083 | 36.81%0.0415 | 0.77%0.1177 | -91.83%0.0139 |
Dividend per share | 0 | 0 | 0 | -25.00%0.05 | 50.00%0.05 | 0 | 0 | 0 | 0.00%0.0667 | -50.00%0.0333 |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data